Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Irina Tsibulak"'
Autor:
Katharina Leitner, Irina Tsibulak, Verena Wieser, Katharina Knoll, Daniel Reimer, Christian Marth, Heidi Fiegl, Alain G. Zeimet
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-11 (2020)
Abstract SMARCA4 and EZH2 are two functional key players of their respective antagonizing chromatin remodeling complexes SWI/SNF and PRC2. EZH2 inhibitory drugs may abrogate pro-oncogenic features of PRC2 and turn the balance to cell differentiation
Externí odkaz:
https://doaj.org/article/c0f898d9b817455c806a36660ea6347a
Autor:
Rüdiger Hochstätter, Anna-Maria Schütz, Nadja Taumberger, Helmar Bornemann-Cimenti, Peter Oppelt, Claudius Fazelnia, Ljubomir Petricevic, Irina Tsibulak, Lisa-Maria Batiduan, Gordana Tomasch, Eva-Christina Weiss, Karl Tamussino, Philipp Metnitz, Herbert Fluhr, Wolfgang Schöll
Publikováno v:
European Journal of Obstetrics & Gynecology and Reproductive Biology. 285:81-85
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9b8d91322181c2d5cad3243dc77587fb
https://doi.org/10.1016/j.ejogrb.2023.03.043
https://doi.org/10.1016/j.ejogrb.2023.03.043
Autor:
Verena Wieser, Irina Tsibulak, Daniel Uwe Reimer, Alain Gustave Zeimet, Heidelinde Fiegl, Hubert Hackl, Christian Marth
Publikováno v:
Gynecologic Oncology. 170:290-299
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0e4ee04c0bbd73a7dc8c63bfd715dcbe
https://doi.org/10.1016/j.ygyno.2023.01.034
https://doi.org/10.1016/j.ygyno.2023.01.034
Autor:
Christine Degasper, Andrea Brunner, Natalie Sampson, Irina Tsibulak, Verena Wieser, Hannah Welponer, Christian Marth, Heidi Fiegl, Alain Gustave Zeimet
Publikováno v:
Tumor Biology, Vol 41 (2019)
The aim of this study was to explore the role of NOX4 in the biology of the normal endometrium and endometrial cancer. NOX4 plays a key role in other adenocarcinomas and has been implicated in the pathogenesis of diabetes and obesity, which are impor
Externí odkaz:
https://doaj.org/article/96f7056c81634b64881b87d2eb91e453
Autor:
Philipp Harter, Frederik Marmé, Klaus Pietzner, Alexander Reuss, Isabelle Ray-Coquard, Andrés Redondo, Ana Oaknin, Goda Jonuskiene, Kristina Lindemann, Christian Kurzeder, Jens Huober, Els van Nieuwenhuysen, Stephanie Henry, Christian Marth, Irina Tsibulak, Nadin Cron, Patricia Pautier
Publikováno v:
Ovarian cancer.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5995a7865aaca9df592dc2fb2ce57057
https://doi.org/10.1136/ijgc-2022-esgo.626
https://doi.org/10.1136/ijgc-2022-esgo.626
Autor:
Esra Bilir, Wasim Ahmed, Joanna Kacperczyk-Bartnik, Sara Nasser, Pernille Bjerre Trent, Felix Boria, Irina Tsibulak, Enrique Chacon, Fabio Martinelli, Aleksandra Natalia Strojna, Gilberto Morgan, Nicolò Bizzarri, Ane Gerda Eriksson, Charalampos Theofanakis
Publikováno v:
International Journal of Gynecologic Cancer. :ijgc-2023
ObjectiveThe primary objective was to reveal the impact of social media ambassadors and the collaboration between the European Society of Gynaecological Oncology (ESGO) and the OncoAlert Network on Twitter during the ESGO 2022 Congress by comparing i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ab496605543ae6a4d1a00921aa62df27
https://doi.org/10.1136/ijgc-2023-004371
https://doi.org/10.1136/ijgc-2023-004371
Autor:
Irina Tsibulak, Stephan Polterauer, Alexander Reinthaller, Christian Schauer, Jürg Berger, Christian Marth
Publikováno v:
Wiener klinische Wochenschrift. 134(19-20)
Summary Background Front-line maintenance therapy with bevacizumab demonstrates high efficacy and safety in epithelial ovarian cancer, as already shown in large phase III trials; however, the corresponding study populations are often not fully repres
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a200c4ba83e0cca7fdfec9248e9b67c
https://pubmed.ncbi.nlm.nih.gov/35146539
https://pubmed.ncbi.nlm.nih.gov/35146539
Autor:
Florence Joly, Sylvie Chabaud, Claire Cropet, Amélie Anota, Martin Demarchi, Beyhan Atasevan, Carmen Pisano, Nuria Lainez, Irina Tsibulak, Kan Yonemori, Ignace Vergote, Maria Lapresa, Mansoor Raza Mirza, Cecile Guillemet, Alexander Burges, Giovanni Scambia, Eugenia Ortega Izquierdo, Eric Pujade-Lauraine, Jean Emmanuel Kurtz, Isabelle Laure Ray-Coquard
Publikováno v:
Journal of Clinical Oncology. 40:5562-5562
5562 Background: In the Phase III PAOLA-1/ENGOT-ov25 trial (NCT02477644), maintenance olaparib plus bevacizumab (bev) provided a significant progression-free survival (PFS) benefit, compared with placebo plus bev, in patients (pts) with newly diagnos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::61ad166240399eaca8976c076e2cf351
https://doi.org/10.1200/jco.2022.40.16_suppl.5562
https://doi.org/10.1200/jco.2022.40.16_suppl.5562
Autor:
Katharina, Knoll, Elisabeth, Reiser, Katharina, Leitner, Johanna, Kögl, Christoph, Ebner, Christian, Marth, Irina, Tsibulak
Publikováno v:
Archives of gynecology and obstetrics. 305(4)
The aim of the present study was to assess the impact of postponed screening examinations and lockdown measures on gynecological and breast cancer diagnoses throughout the year 2020 in a gynecological oncological center in Austria.Data of 889 patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b280a81eba448bcaa2e03ca1d1628c19
https://pubmed.ncbi.nlm.nih.gov/34559295
https://pubmed.ncbi.nlm.nih.gov/34559295
